Bone-Bound Bisphosphonates Inhibit Proliferation of Breast Cancer Cells

In conclusion, bone-bound zoledronate inhibits breast cancer cell proliferation, an activity that may contribute to its clinical anti-tumour effects.
Source: Calcified Tissue International - Category: Orthopaedics Source Type: research